Medicus Pharma Advances Transformation Into A Precision Oncology-Led Biotechnology Company
MDCX•Company transformation and strategic priority
- Medicus Pharma advances transformation into a precision oncology-led biotechnology company
- Medicus Pharma said CD228V has been established as the principal strategic priority for the company.
